Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Atmos Energy Corporation (ATO) vs Eli Lilly And Co (LLY) Price & Performance

Atmos Energy CorporationTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Atmos Energy Corporation vs Eli Lilly And Co — how do they compare? Atmos Energy Corporation trades at $168.76 (market cap $28.38B), while Eli Lilly And Co trades at $1,215 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 38.8× Atmos Energy Corporation's market cap, and Atmos Energy Corporation pays the higher dividend (2.38%). Which is the better fit depends on your goals.

ATOLLY
Market Cap
$28.38B$1.10T
Sector
UtilitiesHealth
52-Week High
$192.25$1.24K
52-Week Low
$162.44$639.43
Enterprise Value
$38.18B$1.14T
Dividend Yield
2.38%0.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Atmos Energy Corporation

Atmos Energy (ATO) trades at $170.19, down 1.04% today, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 EPS of $1.43, beating expectations by 5.9%, and maintains strong fundamentals with 28.5% net income margin and $4.70B revenue. Recent board appointments and dividend declarations highlight corporate stability, while analyst consensus targets $190.57 with 45% buy ratings.

ATO presents a mixed outlook with solid earnings growth and dividend stability offset by bearish technical indicators and negative cash flow trends. The stock offers value through consistent profitability and infrastructure investments, though investors face risks from high capital expenditures and debt levels that could pressure future returns.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,185.71, down 0.59% on the day, with a bullish technical signal from moving averages and strong fundamental momentum. The company reported Q2 2026 revenue growth of 48% to $23 billion, beating estimates, driven by demand for Mounjaro and Zepbound. Valuation ratios like P/E of 39.8 and P/S of 13.34 reflect high growth expectations, while profitability remains robust with a net income margin of 33.53%.

Outlook is positive due to pipeline advancements like retatrutide and raised 2026 guidance, but risks include competitive pressures and regulatory scrutiny. Analysts are bullish with a consensus price target of $1,380, citing sustained double-digit growth and market leadership in weight-loss drugs as key drivers for upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Atmos Energy Corporation

Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.

Read more on ATO

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY